New Process Protects Against Counterfeiting

Patent have developed a supplier MiDSi GmbH & co. KG-researchers of the University of Regensburg and the University of Regensburg in cooperation with MiDSi GmbH & co. KG, for innovative communication systems, a new system for the detection of counterfeit medicines. The process is characterized by its high safety standard and the direct involvement of the consumer in the product review. “” A.j”, Dolce & banana”or Heimekem”: counterfeiting can pretty crude.

But they are not uncommon to distinguish first from the original. Then, the counterfeiting of products can have serious consequences. Each year high losses, so, the producers in the apparel industry. It is particularly problematic but when counterfeit or illegal counterfeit medicines. You pose a double threat. One is the active ingredient in the drug not achieved the desired effect, often sustaining life, since even not or only to a small degree. On the other hand can due to workmanship get dangerous impurities in the drug.

The extent of counterfeit drugs, which is estimated at a market value of more than one billion euros per year, is increasingly menacing. Already cases are known where fake drugs have reached about normal pharmacies to consumers. A new procedure, which was developed by Prof. Dr. Oliver Reiser by the Institute of organic chemistry of the University of Regensburg, in cooperation with MiDSi GmbH & co. KG in Baiersdorf, could make future counterfeit drugs kill. A patent for the system has been granted recently by the German Patent Office. The European and worldwide registration is also already done. Researchers in the development of the new system on a solution approach to combating drug counterfeiting recourse, which appears easy at first glance: counterfeit drugs could prevent sufficient if first of all the manufacturers individually identifies the drugs so each individual Tablet or at least any single drug box provides with a unique identification number. The consumers should then are put in the position about via the Internet or the phone similar to clearly make this identification number a PIN request when making a transfer. While the labelling of a drug the manufacturer is technically possible, a problem arises however the consumer query page. So the code to be entered may have been also forged and deposited by manipulating data in the database, that should confirm the code in the query as right.

The MiDSi GmbH & co. KG and succeeded Professor Reiser, eliminate this weakness. Through a sophisticated system of database code that you want to verify the authenticity of a product, produced only at the moment of the query by the consumer. A previous manipulation is made this impossible. Each access code is also only once can be used. The new system can be easily expanded, so that the entire Retail chain of a product can be tracked and verified. First and foremost, the high safety standards of the system, as well as the simple inclusion of the end user in the product review convinced the German Patent Office.

Comments are closed.